Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vergani

Showing results (1-10 of 249) with videos related to

Pageof 25
Sort By:
Gut|August 14, 1999
NOSA in HCV infection: markers or makers of disease?D Vergani
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1986
ComplementD Vergani
Gut|March 15, 2000
LKM antibody: getting in some target practiceD Vergani
Cahiers D'Anesthesiologie|October 1, 1987
[Immunological aspects of halothane hepatoxicity]D Vergani
Diabetes/Metabolism Reviews|March 30, 1999
MHC restriction to T-cell autoaggression: an emerging understanding of IDDM pathogenesisK Choudhuri, D Vergani
Hormone and Metabolic Research. Supplement Series|January 1, 1992
A new ELISA measuring antibodies to islet cell membranes: levels are increased in type 1 diabetesM Peakman, D Vergani
Immunology Today|August 1, 1994
Autoimmune disease: etiology, therapy and regenerationM Peakman, D Vergani
Current Opinion in Gastroenterology|October 13, 2006
Autoimmune hepatitisD Vergani, G Mieli-Vergani
Lupus|December 1, 1992
Complement and lupus: old concepts and new directionsJ M Porcel, D Vergani
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|April 1, 1996
Autoimmune hepatitisD Vergani, G Mieli-Vergani
Pageof 25

Showing results (1-10 of 249) with videos related to

Sort By:
Pageof 25
Gut|August 14, 1999
NOSA in HCV infection: markers or makers of disease?D Vergani
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1986
ComplementD Vergani
Gut|March 15, 2000
LKM antibody: getting in some target practiceD Vergani
Cahiers D'Anesthesiologie|October 1, 1987
[Immunological aspects of halothane hepatoxicity]D Vergani
Diabetes/Metabolism Reviews|March 30, 1999
MHC restriction to T-cell autoaggression: an emerging understanding of IDDM pathogenesisK Choudhuri, D Vergani
Hormone and Metabolic Research. Supplement Series|January 1, 1992
A new ELISA measuring antibodies to islet cell membranes: levels are increased in type 1 diabetesM Peakman, D Vergani
Immunology Today|August 1, 1994
Autoimmune disease: etiology, therapy and regenerationM Peakman, D Vergani
Current Opinion in Gastroenterology|October 13, 2006
Autoimmune hepatitisD Vergani, G Mieli-Vergani
Lupus|December 1, 1992
Complement and lupus: old concepts and new directionsJ M Porcel, D Vergani
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|April 1, 1996
Autoimmune hepatitisD Vergani, G Mieli-Vergani
Pageof 25